173 related articles for article (PubMed ID: 26035378)
1. Molecular characterization of hepatocarcinogenesis using mouse models.
Teoh WW; Xie M; Vijayaraghavan A; Yaligar J; Tong WM; Goh LK; Sabapathy K
Dis Model Mech; 2015 Jul; 8(7):743-53. PubMed ID: 26035378
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
3. Mutational spectra of aflatoxin B
Chawanthayatham S; Valentine CC; Fedeles BI; Fox EJ; Loeb LA; Levine SS; Slocum SL; Wogan GN; Croy RG; Essigmann JM
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3101-E3109. PubMed ID: 28351974
[TBL] [Abstract][Full Text] [Related]
4. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model.
Anfuso B; El-Khobar KE; Ie SI; Avellini C; Radillo O; Raseni A; Tiribelli C; Sukowati CHC
Sci Rep; 2018 Sep; 8(1):13168. PubMed ID: 30177788
[TBL] [Abstract][Full Text] [Related]
5. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver.
Tilton SC; Gerwick LG; Hendricks JD; Rosato CS; Corley-Smith G; Givan SA; Bailey GS; Bayne CJ; Williams DE
Toxicol Sci; 2005 Dec; 88(2):319-30. PubMed ID: 16141433
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
[TBL] [Abstract][Full Text] [Related]
7. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
8. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.
Schröder PC; Segura V; Riezu JI; Sangro B; Mato JM; Prieto J; Santamaría E; Corrales FJ
Funct Integr Genomics; 2011 Sep; 11(3):419-29. PubMed ID: 21562899
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin B1 and/or hepatitis B virus induced tumor spectrum in a genetically engineered hepatitis B virus expression and Trp53 haploinsufficient mouse model system for hepatocarcinogenesis.
Cullen JM; Brown DL; Kissling GE; Foley JF; Rizzo J; Marion PL; Parron VI; French JE
Toxicol Pathol; 2009 Apr; 37(3):333-42. PubMed ID: 19258306
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
11. Integrative genomic analysis of mouse and human hepatocellular carcinoma.
Dow M; Pyke RM; Tsui BY; Alexandrov LB; Nakagawa H; Taniguchi K; Seki E; Harismendy O; Shalapour S; Karin M; Carter H; Font-Burgada J
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9879-E9888. PubMed ID: 30287485
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.
Friemel J; Frick L; Unger K; Egger M; Parrotta R; Böge YT; Adili A; Karin M; Luedde T; Heikenwalder M; Weber A
Mol Cancer Res; 2019 Jul; 17(7):1493-1502. PubMed ID: 30967480
[TBL] [Abstract][Full Text] [Related]
13. Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1.
Yan RQ; Su JJ; Huang DR; Gan YC; Yang C; Huang GH
J Cancer Res Clin Oncol; 1996; 122(5):289-95. PubMed ID: 8609152
[TBL] [Abstract][Full Text] [Related]
14. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
15. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.
Fox JG; Feng Y; Theve EJ; Raczynski AR; Fiala JL; Doernte AL; Williams M; McFaline JL; Essigmann JM; Schauer DB; Tannenbaum SR; Dedon PC; Weinman SA; Lemon SM; Fry RC; Rogers AB
Gut; 2010 Jan; 59(1):88-97. PubMed ID: 19850960
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis and hepatocarcinogenesis in the transgenic mice].
Hino O
Nihon Rinsho; 1993 Feb; 51(2):531-5. PubMed ID: 8464165
[TBL] [Abstract][Full Text] [Related]
17. [Differentially expressed genes in hepatocellular carcinoma of tree shrew induced by different factors].
Li Y; Su JJ; Cao J; Ou C; Qiu XK; Yang C; Ban KC; Yue HF; Wei W; Ou SJ; Zhang LS; Wan DF; Gu JR
Ai Zheng; 2003 Oct; 22(10):1018-22. PubMed ID: 14558942
[TBL] [Abstract][Full Text] [Related]
18. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice.
Wang Y; Cui F; Lv Y; Li C; Xu X; Deng C; Wang D; Sun Y; Hu G; Lang Z; Huang C; Yang X
Hepatology; 2004 Feb; 39(2):318-24. PubMed ID: 14767984
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B.
Nosaka T; Naito T; Hiramatsu K; Ohtani M; Nemoto T; Marusawa H; Ma N; Hiraku Y; Kawanishi S; Yamashita T; Kaneko S; Nakamoto Y
PLoS One; 2017; 12(10):e0185442. PubMed ID: 28968425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
